Last 12 months
Inside the activity.
3 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2024 Filed Aug 23, 2024 20:07 UTC |
Peng KatieDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 70,200 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100178 · ownership.xml · derivative · entry 1 Peng Katie · CIK 0001983850 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,200 shares Expires 2033-07-09 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on July 10, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $5.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 10 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 9 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $11.49 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 8 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 7 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,172 | $0.00 Strike: $15.93 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 6 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,172 Underlying: Common Stock · 8,172 shares Expires 2031-04-29 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 8,172 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 5 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,172 shares Expires 2031-04-29 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $15.93 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 4 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 3 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,828 | $0.00 Strike: $15.75 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 2 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,828 Underlying: Common Stock · 28,828 shares Expires 2031-03-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
Sinclair AndrewDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 28,828 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100180 · ownership.xml · derivative · entry 1 Sinclair Andrew · CIK 0001762451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,828 shares Expires 2031-03-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $5.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 8 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 7 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $11.49 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 6 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 5 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $15.93 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 4 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 3 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $16.11 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 2 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:08 UTC |
GORDON CARL LDirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100179 · ownership.xml · derivative · entry 1 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $5.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 8 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 7 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $11.49 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 6 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $15.93 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $16.11 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
Chodakewitz JeffreyDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100176 · ownership.xml · derivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $5.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 8 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 7 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $11.49 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 6 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 5 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $15.93 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 4 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 3 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $16.11 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 2 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:06 UTC |
DUBIN STEVEDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100174 · ownership.xml · derivative · entry 1 DUBIN STEVE · CIK 0001265123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:05 UTC |
Kauffman MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $5.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100173 · ownership.xml · derivative · entry 6 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:05 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100173 · ownership.xml · derivative · entry 5 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:05 UTC |
Kauffman MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $11.49 | $0.00 |
DisclosureSEC source: 0000950170-24-100173 · ownership.xml · derivative · entry 4 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:05 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100173 · ownership.xml · derivative · entry 3 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F3 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:05 UTC |
Kauffman MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $9.39 | $0.00 |
DisclosureSEC source: 0000950170-24-100173 · ownership.xml · derivative · entry 2 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2031-11-16 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on November 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:05 UTC |
Kauffman MichaelDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100173 · ownership.xml · derivative · entry 1 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2031-11-16 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on November 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $5.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 8 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 7 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2033-05-31 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $11.49 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 6 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 5 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2032-06-01 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $15.93 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 4 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 18,500 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 3 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,500 shares Expires 2031-04-29 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $16.11 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 2 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · derivative.exercise_price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:04 UTC |
Jakobovits AyaDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0000950170-24-100165 · ownership.xml · derivative · entry 1 Jakobovits Aya · CIK 0001823901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-09-16 F1 · kind: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · price: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F2 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 20:05 UTC |
Klickstein LloydDirector
|
GrantStock Option (Right to Buy) · Derivative | 70,200 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0000950170-24-099073 · ownership.xml · derivative · entry 1 Klickstein Lloyd · CIK 0001776004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,200 Underlying: Common Stock · 70,200 shares Expires 2034-08-18 F1 · derivative.exercise_date: These shares shall vest in thirty-six (36) equal monthly installments following August 19, 2024; provided, however, that all vesting shall cease if the Reporting Person resigns from the Issuer's Board of Directors or otherwise ceases to serve as a director of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.